CClinicalTrials.gg
CompletedNCT02296866Updated Dec 30, 2014

Assessment of Prokinetic Effects of Erythromycin in Emergency Patients With a Full Stomach

An observational study in Emergency Surgery and Full Stomach, sponsored by Lionel Bouvet. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-30.

Sponsored by Lionel Bouvet · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
28
Ages
18 Years and older
Sex
All
01

Study summary

The aims of the study is to assess whether the intravenous infusion of 3 mg/kg erythromycin has a significant gastrokinetic effect leading to empty the stomach in less than 90 minutes in non-fasting patients undergoing emergency trauma surgery.

02

Conditions studied

  • Emergency Surgery
  • Full Stomach

Browse trials for

03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 28 is below the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Lionel Bouvet is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

all trauma patients with a full stomach, undegoing emergency surgery

Inclusion criteria

  • Emergency surgery for trauma
  • ASA 1 and 2 patients
  • Full stomach (antral area > 550 mm²)
  • Adult patients

Exclusion criteria

Exclusion Criteria:

  • No contraindication to erythromycin
  • Extreme emergency surgery (time frame \< 90 min between arrival in the service and the start of the surgery)
  • gastroparesis or pathology associated with gastroparesis
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
28 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. ultrasonographic measurement of antral area

    Time frame: 30 minutes and immediately before erythromycin infusion, and 30, 60 and 90 min after the start of erythromycin infusion

07

Study locations

1 site
  • Hopital Edouard Herriot
    Lyon, 69003, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 30, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02296866
Lead sponsor
Lionel Bouvet
Responsible party
Lionel Bouvet (MD PhD, Hôpital Edouard Herriot) — Sponsor-investigator
First posted
Nov 20, 2014
Start date
Sep 2014
Primary completion
Nov 2014
Completion
Nov 2014
Last update
Dec 30, 2014
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion